Bank of America’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.96M Buy
395,054
+21,830
+6% +$381K ﹤0.01% 3429
2026
Q1
$7.15M Sell
373,224
-329,279
-47% -$7.15M ﹤0.01% 3200
2025
Q4
$15.4M Buy
702,503
+44,150
+7% +$797K ﹤0.01% 2508
2025
Q3
$7.99M Buy
658,353
+112,849
+21% +$1.53M ﹤0.01% 3527
2025
Q2
$10.2M Buy
545,504
+78,774
+17% +$1.56M ﹤0.01% 3208
2025
Q1
$8.94M Buy
466,730
+149,024
+47% +$4.36M ﹤0.01% 3244
2024
Q4
$11.4M Sell
317,706
-127,904
-29% -$4.33M ﹤0.01% 2813
2024
Q3
$18.9M Sell
445,610
-187,261
-30% -$7.94M ﹤0.01% 2451
2024
Q2
$25.5M Buy
632,871
+96,700
+18% +$4.03M ﹤0.01% 2013
2024
Q1
$19M Buy
536,171
+453,299
+547% +$12.1M ﹤0.01% 2343
2023
Q4
$2.45M Sell
82,872
-7,312
-8% -$152K ﹤0.01% 4205
2023
Q3
$1.87M Buy
90,184
+5,049
+6% +$139K ﹤0.01% 4312
2023
Q2
$2.09M Sell
85,135
-170,300
-67% -$5.48M ﹤0.01% 4195
2023
Q1
$10.4M Buy
255,435
+139,463
+120% +$5.77M ﹤0.01% 2792
2022
Q4
$5.21M Sell
115,972
-12,526
-10% -$567K ﹤0.01% 3349
2022
Q3
$6.15M Sell
128,498
-95,317
-43% -$5.23M ﹤0.01% 3119
2022
Q2
$13.2M Buy
223,815
+119,992
+116% +$9.85M ﹤0.01% 2395
2022
Q1
$12.1M Sell
103,823
-17,942
-15% -$2.09M ﹤0.01% 2680
2021
Q4
$18.3M Buy
121,765
+12,003
+11% +$1.62M ﹤0.01% 2302
2021
Q3
$13.1M Buy
109,762
+3,991
+4% +$440K ﹤0.01% 2567
2021
Q2
$10.3M Buy
105,771
+14,572
+16% +$1.3M ﹤0.01% 2825
2021
Q1
$8.05M Buy
91,199
+7,703
+9% +$716K ﹤0.01% 2933
2020
Q4
$7.99M Sell
83,496
-91,248
-52% -$9.4M ﹤0.01% 2716
2020
Q3
$19.8M Buy
174,744
+2,881
+2% +$303K ﹤0.01% 1711
2020
Q2
$17M Buy
171,863
+76,482
+80% +$6.1M ﹤0.01% 1741
2020
Q1
$6.14M Sell
95,381
-9,148
-9% -$641K ﹤0.01% 2486
2019
Q4
$6.23M Sell
104,529
-8,742
-8% -$539K ﹤0.01% 3032
2019
Q3
$6.68M Sell
113,271
-12,888
-10% -$823K ﹤0.01% 2922
2019
Q2
$8.14M Buy
126,159
+30,215
+31% +$1.95M ﹤0.01% 2768
2019
Q1
$6.09M Sell
95,944
-25,507
-21% -$1.34M ﹤0.01% 2963
2018
Q4
$4.61M Buy
121,451
+86,763
+250% +$3.06M ﹤0.01% 3077
2018
Q3
$1.49M Buy
34,688
+28,752
+484% +$1M ﹤0.01% 4205
2018
Q2
$130K Sell
5,936
-492
-8% -$6.05K ﹤0.01% 5659
2018
Q1
$32K Buy
6,428
+6,407
+30,510% +$20.7K ﹤0.01% 6213
2017
Q4
$0 Sell
21
-209
-91% -$656 ﹤0.01% 7254
2017
Q3
$2K Sell
230
-49,605
-100% -$314K ﹤0.01% 6872
2017
Q2
$399K Sell
49,835
-36,268
-42% -$335K ﹤0.01% 5013
2017
Q1
$1.03M Buy
86,103
+40,446
+89% +$884K ﹤0.01% 4401
2016
Q4
$982K Buy
45,657
+34,170
+297% +$1.31M ﹤0.01% 4356
2016
Q3
$880K Buy
11,487
+10,858
+1,726% +$792K ﹤0.01% 4252
2016
Q2
$47K Sell
629
-28,064
-98% -$2.26M ﹤0.01% 5856
2016
Q1
$2.5M Buy
28,693
+1,594
+6% +$139K ﹤0.01% 3384
2015
Q4
$3.2M Sell
27,099
-5,613
-17% -$557K ﹤0.01% 3377
2015
Q3
$2.88M Buy
32,712
+26,775
+451% +$3.12M ﹤0.01% 3423
2015
Q2
$644K Sell
5,937
-2,814
-32% -$350K ﹤0.01% 4501
2015
Q1
$1.1M Sell
8,751
-1,202
-12% -$156K ﹤0.01% 3705
2014
Q4
$1.26M Sell
9,953
-1,030
-9% -$143K ﹤0.01% 3844
2014
Q3
$1.47M Buy
10,983
+1,858
+20% +$260K ﹤0.01% 3654
2014
Q2
$1.48M Buy
9,125
+9,113
+75,942% +$1.55M ﹤0.01% 3638
2014
Q1
$3K Sell
12
-51
-81% -$13K ﹤0.01% 7476
2013
Q4
$16K Buy
+63
New +$14.4K ﹤0.01% 7123

Other funds holding TNDM

Bank of America's TNDM Position: Q2 2026 in Review

Bank of America increased its Tandem Diabetes Care (TNDM) stake by 5.8% in Q2 2026, buying an estimated $381K and bringing the position to 395,054 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

Bank of America first reported a position in TNDM in Q4 2013 and has held it in 51 quarters since. The position peaked at $25.5M in Q2 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Bank of America held 395,054 shares of Tandem Diabetes Care worth $5.96M as of Q2 2026.
  • Bank of America bought 21,830 Tandem Diabetes Care shares in Q2 2026, an estimated $381K.
  • Tandem Diabetes Care made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3429 holding.
  • Bank of America first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 51 quarters since.
  • Bank of America's Tandem Diabetes Care position peaked at $25.5M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.